Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126279121 | 12627912 | 1 | I | 20160726 | 20160807 | 20160807 | EXP | GB-MHRA-MIDB-58A4922C-DA19-4D41-A792-960A3D37BD28 | GB-TEVA-681076ACC | TEVA | 80.00 | YR | F | Y | 0.00000 | 20160807 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126279121 | 12627912 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 15 MILLIGRAM DAILY; 15 MG EVERY MORNING | U | 89081 | 15 | MG | TABLET | QD | |||||
| 126279121 | 12627912 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 10 MILLIGRAM DAILY; EVERY MORNING OM, 10 MG DAILY | U | 89081 | 10 | MG | TABLET | QD | |||||
| 126279121 | 12627912 | 3 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Y | U | 76846 | ||||||||||
| 126279121 | 12627912 | 4 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | Oral | 30MG - 60MG THREE TIMES A DAY | 0 | TABLET | |||||||||
| 126279121 | 12627912 | 5 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | 60MG/0.6ML UNTIL INR WITHIN RANGE,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | 0 | SOLUTION FOR INJECTION | |||||||||
| 126279121 | 12627912 | 6 | C | FENBID | IBUPROFEN | 1 | Topical | 0 | GEL | ||||||||||
| 126279121 | 12627912 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 30 MILLIGRAM DAILY; GASTRO-RESISTANT CAPSULE, 30 MG DAILY | 0 | 30 | MG | CAPSULE | QD | ||||||
| 126279121 | 12627912 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 4 GRAM DAILY; | 0 | 1 | G | TABLET | QID | ||||||
| 126279121 | 12627912 | 9 | C | WARFARIN | WARFARIN | 1 | Oral | AS PER INR BOOKLET | Y | 0 | 1 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126279121 | 12627912 | 1 | Rheumatoid arthritis |
| 126279121 | 12627912 | 9 | Deep vein thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126279121 | 12627912 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126279121 | 12627912 | Acute kidney injury | |
| 126279121 | 12627912 | International normalised ratio increased | |
| 126279121 | 12627912 | Joint swelling | |
| 126279121 | 12627912 | Peripheral swelling | |
| 126279121 | 12627912 | Polyarthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126279121 | 12627912 | 2 | 20160520 | 0 |